Supplement brand exit readiness: what a $1.2B exit proves

Unilever closed on Grüns this June, a little over two years after the greens gummy brand shipped its first order. The price was never officially confirmed, but multiple industry outlets, including Axios, put it around $1.2 billion. That number matters less than what it proves: supplement brand exit readiness isn't a hypothetical exercise anymore. It's a deal that already happened, with a timeline you can study.

We've covered the likely acquirer shortlist for brands like this (Unilever, Pharmavite, Bayer, Church & Dwight all sit on it) and the valuation math that gets a supplement brand from $300 million to $1.4 billion-plus elsewhere. This post is about the part that doesn't show up in a valuation model: what a buyer's diligence team actually finds when they open the data room, and what a founder should fix before that happens.

What does supplement brand exit readiness actually mean?

Exit readiness means a brand's growth, its supply chain, and its financials can survive a stranger's scrutiny without surprises. It's not the same as being big enough to sell. Plenty of nine-figure ARR brands aren't ready. Being ready means the retail data reconciles, the manufacturing relationship is documented instead of relational, and the founder can answer "what happens if X breaks" for every X a buyer names.

Grüns hit both marks. It scaled fast and it held up under a real acquirer's diligence. That combination, not the ARR number alone, is what closed the deal.

Where Grüns stood when Unilever came calling

The growth curve is the part everyone quotes, and it's worth laying out in order:

• December 2024: first retail placement, at Sprouts
• February 2025: Target, roughly 1,600 stores
• April 2025: Walmart, roughly 1,900 stores
• May 2025: a $35 million Series B at a $500 million valuation
• August 2025: $300 million in annualized run rate, up from the nine-figure ARR the brand had reported just months earlier
• October 2025: Sam's Club
• March 2026: a nationwide Costco rollout

By the time Unilever's offer landed in April 2026, Grüns was shipping 10 million gummies a day through more than 6,000 retail doors, and it had been profitable since its 14th month in business. The $500 million valuation from that May 2025 raise turned into a reported $1.2 billion exit less than a year later, roughly a 2.4x markup in eleven months.

That's the growth story. It's also the easy part to benchmark against, because it's public. The harder part is what was happening underneath it.

The single-CMO manufacturing risk every acquirer will flag

Before Grüns launched, its founder spent close to a year interviewing 20 contract manufacturers, the co-packers who actually produce the gummies, before finding one capable of the format he wanted: high-active, low-sugar, multi-ingredient. One out of 20.

That's not a Grüns problem. It's a category problem. Gummy manufacturing is a fermentation-and-depositing process closer to specialty candy production than to pill pressing, and very few contract manufacturers can handle a dense, multi-ingredient formula without the batch failing on taste, stability, or shelf life. When a brand finds a partner who can, it tends to run its entire volume through that one relationship, because qualifying a second one takes months and a lot of failed batches.

That concentration is exactly what a buyer's operations diligence team is trained to find. A single contract manufacturer producing 10 million units a day for one brand is a single point of failure: a fire, a labor dispute, a quality recall, or a contract renegotiation at any one facility can stop shipments to every retail account overnight. Acquirers price that risk in, or they make fixing it a condition of the deal. Either way, it shows up in the term sheet, not just the spreadsheet.

Three moves we'd make before a term sheet

If we were sitting across from a supplement founder six months out from a raise or a sale conversation, here's where we'd start.

1. Qualify a second contract manufacturer now, not during diligence. You don't need to split volume today. You need a documented, audited backup that can absorb capacity if the primary relationship breaks. A buyer wants to see that plan already exists, not promised.
2. Turn the manufacturing relationship into a paper trail. Certificates of analysis, batch records, stability testing, and clear IP ownership terms with your co-manufacturer. If that knowledge lives in your founder's head or a group chat with your co-packer, it isn't diligence-ready. It's tribal knowledge, and tribal knowledge doesn't survive a data room.
3. Get your retail data clean before a banker ever sees it. Sell-through, forecast accuracy, and chargeback history across every account, Target, Walmart, Sprouts, whoever you're in, need to reconcile against your own numbers without a finance team spending three weeks explaining the gaps. Clean retail data is as much a signal of exit readiness as the ARR line is.

None of these are big, dramatic fixes. They're the boring, sequential work of making sure nothing you already know about your business is a surprise to someone else.

Why the timing favors sellers right now

Grüns didn't exit into a quiet market. The same week Unilever's deal became public, Henkel acquired Olaplex for a reported $1.4 billion and the Mark Anthony Group, parent of White Claw, bought Long Drink for roughly $325 million. Unilever's own leadership has said the company allocates around 1.5 billion euros a year to acquisitions. Strategic buyers are active in consumer categories right now, supplements included, and that's a window that narrows the longer a brand waits to get its house in order.

That's the piece of supplement brand exit readiness that growth planning has to account for: the work of being ready doesn't start when a term sheet shows up. It starts early enough that when a buyer's team opens the data room, there's nothing in there they didn't already know about.

We've spent a full season of our Ecommerce on Tap podcast digging into supplement brands, including the Grüns story before the acquisition was even announced, and we help brands in this exact position build the operational backbone acquirers look for. If you want a clearer read on where your brand stands, Izba's exit strategy work (opens in new tab) is a good place to start.